Encore webinar and live QA featuring a panel of experts covering estrogen receptor mutations in HR advanced breast cancer including recommendations on mutation screening to guide therapeutic decisionmaking with selective estrogen receptor degraders SERDs This encore presentation and live QA is sponsored by Clinical Care Options LLC and supported by educational grants from AstraZeneca and Lilly
- Provider:Clinical Care Options
- Activity Link: https://clinicaloptions.com/events/er-mutations-in-hr-breast-cancer/er-mutations-in-hr-breast-cancer/16187-22769
- Start Date: 2025-01-31 06:00:00
- End Date: 2025-01-31 06:00:00
- Credit Details: AMA PRA Category 1 Credit™️: 1.5 hours
- MOC Credit Details: ABIM - 1.5 Point; Credit Type(s): Medical Knowledge (ABIM)
- Commercial Support: Source: AstraZeneca (Any division) - Amount: 0.0 - Is Kind Support: False Source: Lilly (Any division) - Amount: 0.0 - Is Kind Support: False
- Activity Type: Live Course
- CME Finder Type: Conference
- Fee to Participate: No, it's free
- Measured Outcome: Learner Knowledge, Learner/Team Competence
- Provider Ship: Directly Provided
- Registration: Open to all
- Specialty: Internal Medicine, Medical Oncology
Subscribe
Login
0 Comments
Oldest